MUS81 and neoplasm: These findings suggest a treatment strategy for BRCA-defective cells in which this MUS81 fork restart pathway is blocked to enhance tumor killing by replication-stress inducing chemotherapy [78]; this strategy might provide similar benefits with radiotherapy.